[go: up one dir, main page]

ES2031302T3 - Procedimiento para la obtencion de un sistema osmotico oral con efecto de adherencia mejorado de la membrana sobre el nucleo. - Google Patents

Procedimiento para la obtencion de un sistema osmotico oral con efecto de adherencia mejorado de la membrana sobre el nucleo.

Info

Publication number
ES2031302T3
ES2031302T3 ES198989107213T ES89107213T ES2031302T3 ES 2031302 T3 ES2031302 T3 ES 2031302T3 ES 198989107213 T ES198989107213 T ES 198989107213T ES 89107213 T ES89107213 T ES 89107213T ES 2031302 T3 ES2031302 T3 ES 2031302T3
Authority
ES
Spain
Prior art keywords
nucleus
procedure
obtaining
osmotic system
oral osmotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989107213T
Other languages
English (en)
Inventor
Shailesh B. Dr. Shah
Arun Dattatreya Koparkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2031302T3 publication Critical patent/ES2031302T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Confectionery (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE UN SISTEMA OSMOTICO ORAL PARA LA APLICACION CONTINUADA Y CONTROLADA DE METAPROLOL EN INTERVALOS DE TIEMPO ALARGADOS QUE CONTIENEN UNA CAPA SEPARADA DE MASA SIEMPRE IGUAL DE AGENTES DE RECUBRIMIENTO SOLUBLES EN AGUA. COMO AGENTES DE RECUBRIMIENTO SE PUEDEN USAR HPMC, PVP, EN SU CASO POLIETILGLICOCOL MEZCLADO CON ELLOS.
ES198989107213T 1988-04-25 1989-04-21 Procedimiento para la obtencion de un sistema osmotico oral con efecto de adherencia mejorado de la membrana sobre el nucleo. Expired - Lifetime ES2031302T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/185,564 US4892739A (en) 1988-04-25 1988-04-25 Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties

Publications (1)

Publication Number Publication Date
ES2031302T3 true ES2031302T3 (es) 1992-12-01

Family

ID=22681522

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989107213T Expired - Lifetime ES2031302T3 (es) 1988-04-25 1989-04-21 Procedimiento para la obtencion de un sistema osmotico oral con efecto de adherencia mejorado de la membrana sobre el nucleo.

Country Status (22)

Country Link
US (1) US4892739A (es)
EP (1) EP0339506B1 (es)
JP (1) JP2750150B2 (es)
KR (1) KR0125935B1 (es)
AT (1) ATE75939T1 (es)
AU (1) AU618083B2 (es)
CA (1) CA1334382C (es)
DD (1) DD288093A5 (es)
DE (1) DE58901373D1 (es)
DK (1) DK175232B1 (es)
ES (1) ES2031302T3 (es)
FI (1) FI90203C (es)
GR (1) GR3005399T3 (es)
HU (1) HU201469B (es)
IE (1) IE61223B1 (es)
IL (1) IL90019A (es)
MX (1) MX15754A (es)
NO (1) NO175186C (es)
NZ (1) NZ228845A (es)
PH (1) PH27150A (es)
PT (1) PT90341B (es)
ZA (1) ZA892998B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
BR0115390A (pt) 2000-11-03 2004-02-25 Andrx Corp Formulações para liberação controlada de metformina, liberação controlada da forma farmacêutica oral, método de diminuição dos nìveis de glicose sanguìnea, uso da forma farmacêutica
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
CA2452738C (en) * 2001-07-04 2011-06-14 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
WO2003099214A2 (en) * 2002-05-23 2003-12-04 Andrx Corporation Biguanide formulations
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
KR20100137023A (ko) 2002-09-20 2010-12-29 안드렉스 랩스 엘엘씨 약제학적 정제
AU2003903507A0 (en) 2003-07-08 2003-07-24 U. S. Filter Wastewater Group, Inc. Membrane post-treatment
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
DE602005015198D1 (de) * 2004-03-05 2009-08-13 Mcneil Ppc Inc Polymer-zusammensetzungen und diese enthaltende dosierformen
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
CA2571502A1 (en) * 2004-07-05 2006-01-12 U.S. Filter Wastewater Group, Inc. Hydrophilic membranes
IL166114A0 (en) * 2005-01-03 2006-01-15 Calcident Active Ltd Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
CN102670555A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 富马酸美托洛尔渗透泵控释片
CN102670539A (zh) * 2011-03-14 2012-09-19 北京天衡药物研究院 琥珀酸美托洛尔渗透泵控释片
CN104684632A (zh) 2012-09-14 2015-06-03 伊沃夸水处理技术有限责任公司 用于膜的聚合物共混物
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN107847869B (zh) 2015-07-14 2021-09-10 罗门哈斯电子材料新加坡私人有限公司 用于过滤系统的通气装置
EP3826619A1 (de) * 2018-07-24 2021-06-02 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US20230355939A1 (en) * 2020-09-15 2023-11-09 Synagile Corporation Devices and methods for continuous extrusion of a drug into the mouth

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4439195A (en) * 1980-10-14 1984-03-27 Alza Corporation Theophylline therapy
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
EP0271438B1 (de) * 1986-11-14 1992-04-29 Ciba-Geigy Ag Orales osmotisches System für Metoprolol mit verbesserten Formulierungseigenschaften

Also Published As

Publication number Publication date
AU3268789A (en) 1989-10-26
NO891680D0 (no) 1989-04-24
FI891921A7 (fi) 1989-10-26
NO891680L (no) 1989-10-26
DE58901373D1 (de) 1992-06-17
JP2750150B2 (ja) 1998-05-13
ZA892998B (en) 1989-12-27
CA1334382C (en) 1995-02-14
JPH029815A (ja) 1990-01-12
FI891921A0 (fi) 1989-04-21
MX15754A (es) 1994-01-31
AU618083B2 (en) 1991-12-12
DK175232B1 (da) 2004-07-19
KR0125935B1 (ko) 1997-12-26
EP0339506A1 (de) 1989-11-02
KR900015734A (ko) 1990-11-10
DD288093A5 (de) 1991-03-21
IE891316L (en) 1989-10-25
NO175186B (es) 1994-06-06
NZ228845A (en) 1990-10-26
HUT50625A (en) 1990-03-28
FI90203C (fi) 1994-01-10
ATE75939T1 (de) 1992-05-15
DK196189D0 (da) 1989-04-24
PT90341A (pt) 1989-11-10
PT90341B (pt) 1994-08-31
IL90019A (en) 1994-04-12
EP0339506B1 (de) 1992-05-13
IE61223B1 (en) 1994-10-19
FI90203B (fi) 1993-09-30
NO175186C (no) 1994-09-14
US4892739A (en) 1990-01-09
PH27150A (en) 1993-04-02
GR3005399T3 (es) 1993-05-24
DK196189A (da) 1989-10-26
HU201469B (en) 1990-11-28
IL90019A0 (en) 1989-12-15

Similar Documents

Publication Publication Date Title
ES2031302T3 (es) Procedimiento para la obtencion de un sistema osmotico oral con efecto de adherencia mejorado de la membrana sobre el nucleo.
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
UY26527A1 (es) Sistema de suministro de droga por difusión/bombeo osmótico combinados
ES2034365T3 (es) Una goma de mascar con blandura duradera.
ES2059729T3 (es) Preparado farmaceutico de liberacion controlada y metodo para producir el mismo.
ES2010648A4 (es) Formulaciones farmaceuticas de sustancias labiles frente a los acidospara uso oral.
DE3687458D1 (de) Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
ES2094694B1 (es) Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
DK344586A (da) Tidskontrolleret laegemiddelafgivelse
ES2125380T3 (es) Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos.
ATE53176T1 (de) Pharmazeutische zusammensetzung mit verzoegerter abgabe.
MX10086A (es) Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
FI924419A0 (fi) Ett osmotiskt doseringssystem foer frigoerande av laekemedel i vaetskeform.
NO20053307L (no) Oralt administrerbart preparat for angivelse av virksomme stoffer i munnhulen og fremgangsmate for fremstilling derav.
FI853934L (fi) Doseringssystem som bestaor av flera enheter och har en belaeggning som tillaoter diffusion.
AR012927A1 (es) Una composicion farmaceutica, una forma de dosificacion farmaceutica, el uso de dicha composicion para la fabricacion de un medicamento y una forma depresentacion farmaceutica adecuada para la venta comercial
AR241676A1 (es) Suministrador de agente beneficioso a un ambiente de uso.
CO4520286A1 (es) Procedimiento para preparar clorhidrato de 1-(2 -desoxi-2 , 2 -difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona
ES2116572T3 (es) Parche para la administracion percutanea de sustancias de contenido quimicamente basico, farmaceuticamente eficaces y volatiles, y un metodo para su fabricacion.
ATE43497T1 (de) Pharmazeutische formulierung mit gesteuerter absorption.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
CY1107923T1 (el) Τυποποιησεις ελεγχομενης απελευθερωσης χορηγουμενες απο του στοματος
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2040891T3 (es) Nuevo sistema plastificante hidrofilo y goma de mascar que contiene el mismo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 339506

Country of ref document: ES